These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22362231)

  • 1. Pisa syndrome secondary to rivastigmine: a case report.
    Leelavathi M; Rosdinom R; Suguna M
    Clin Ter; 2012; 163(1):31-2. PubMed ID: 22362231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
    Stevens DL; Lee MR; Padua Y
    Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
    Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
    J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
    Cummings JL
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):903-4. PubMed ID: 15965192
    [No Abstract]   [Full Text] [Related]  

  • 6. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
    Inglis F
    Int J Clin Pract Suppl; 2002 Jun; (127):45-63. PubMed ID: 12139367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
    Rösler M
    Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between cholinesterase inhibitor and Pisa syndrome.
    Kwak YT; Han IW; Baik J; Koo MS
    Lancet; 2000 Jun; 355(9222):2222. PubMed ID: 10881902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
    Alwahhabi FK
    J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
    Leikin JB; Braund V; DesLauris C
    Am J Emerg Med; 2014 Jul; 32(7):815.e3-4. PubMed ID: 24589024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
    Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M
    J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
    Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
    Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
    Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U
    Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases].
    Ueda A; Komatsu K; Takahashi M
    Rinsho Shinkeigaku; 2023 Feb; 63(2):85-91. PubMed ID: 36725013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug utilization review of cholinesterase inhibitors in Quebec.
    Massoud F; Dorais M; Charbonneau C; Lescrauwaet B; Boucher JM; LeLorier J
    Can J Neurol Sci; 2008 Sep; 35(4):508-9. PubMed ID: 18973072
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinesterase inhibitors in the treatment of dementia.
    Ellis JM
    J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.